RE:RE:RE:saleCN: I think your bang on, and this is the way I see it as well. Now that PE have been in to see CXRs books at a detailed level they can afford to wait with this depressed stock price. After next quarter results they will update CXR model and then start to do some serious thinking as they continue to derisk the play.
Only chance of a buyout soon is if they feel confident in meeting 2016 guidance and agressive short covering forces a prompt decision .
Do these Pharma companies announce drug roll outs as they happen or do they typically announce at the Quarter, when possible?
And for 60 drugs to be rolled out aren't we expecting a few more shortly. I've only seen 3 or 4 at the start of the year?